Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer (Q33597715)

28 July 2017

title

Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer (English)

1 reference

28 July 2017

7

P J Selby

0 references

author name string

S L Wood

1

1 reference

28 July 2017

M Rogers

2

1 reference

28 July 2017

D A Cairns

3

1 reference

28 July 2017

A Paul

4

1 reference

28 July 2017

D Thompson

5

1 reference

28 July 2017

N S Vasudev

6

1 reference

28 July 2017

R E Banks

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

8 June 2010

1 reference

British Journal of Cancer

28 July 2017

published in

1 reference

28 July 2017

volume

103

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

101-111

1 reference

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles--initial evaluation using low molecular weight serum peaks

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Integrated multi-level quality control for proteomic profiling studies using mass spectrometry

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Prognostic models and algorithms in renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Serum amyloid A: an acute-phase protein involved in tumour pathogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Proteomic contributions to personalized cancer care.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Preoperative nomogram predicting 12-year probability of metastatic renal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Mathematical models for prognostic prediction in patients with renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Applications of SELDI-MS technology in oncology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Serum and plasma proteomics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Microarray gene expression profiling and analysis in renal cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Detection of novel truncated forms of human serum amyloid A protein in human plasma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Composition of the peptide fraction in human blood plasma: database of circulating human peptides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

Characterization of human serum amyloid A protein isoforms separated by two-dimensional electrophoresis by liquid chromatography/electrospray ionization tandem mass spectrometry

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

The acute phase protein response in patients receiving subcutaneous IL-6.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905280

A preoperative clinical prognostic model for non-metastatic renal cell carcinoma.

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Urinary biomarker profiling in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Cathepsin D activity protects against development of type AA amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605720

Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome

21 January 2018

1 reference

12 December 2020

C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality

1 reference

12 December 2020

Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma

1 reference

12 December 2020

Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma

1 reference

12 December 2020

Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients

1 reference

12 December 2020

Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6605720

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference